The dysregulation of alternative splicing (AS) has emerged as a mechanism of acute myeloid leukemia (AML). However. the prognostic impact of AS events remains under-explored in AML. Here we report the prognostic value of AS events and associated splicing factors based on three datasets of AML patients. https://www.diegojavierfares.com/mega-buy-Exedy-Stage-2-Cerametallic-Clutch-Kit-22-24-Civic-SI-hot-choice/